vancomycin has been researched along with Respiratory Tract Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Astolfi, D; Balbinot, A; Bianco, A; Catavitello, C; D'Amario, C; D'Antonio, D; Febbo, F; Masciarelli, G; Savini, V | 1 |
Amren, DP; Bisno, AL; Dajani, AS; Durack, DT; Gerber, MA; Kaplan, EL; Millard, HD; Sanders, WE; Schwartz, RH; Shulman, ST | 1 |
1 review(s) available for vancomycin and Respiratory Tract Diseases
Article | Year |
---|---|
Review of airway illnesses by kytococcus and rothia and a look at inhalatory vancomycin as a treatment support.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Gram-Positive Bacteria; Humans; Respiratory Tract Diseases; Vancomycin | 2011 |
1 other study(ies) available for vancomycin and Respiratory Tract Diseases
Article | Year |
---|---|
Prevention of bacterial endocarditis. A statement for health professionals by the Committee on Rheumatic Fever and Bacterial Endocarditis of the Council on Cardiovascular Diseases in the Young of the American Heart Association.
Topics: American Hospital Association; Ampicillin; Anti-Bacterial Agents; Cardiac Surgical Procedures; Dentistry, Operative; Endocarditis, Bacterial; Female; Gastrointestinal Diseases; Genital Diseases, Female; Genital Diseases, Male; Gentamicins; Humans; Male; Penicillin V; Postoperative Complications; Premedication; Respiratory Tract Diseases; Risk; Sepsis; United States; Vancomycin | 1985 |